Latest Kaiser Health News Stories
An Instagram community of “doll pages” lets women find valuable information about body-sculpting journeys.
Capitalizing on the growing popularity of genetic testing — and fears of terminal illness — scammers are persuading seniors to hand over cheek swabs with their DNA, not knowing it may lead to identity theft and Medicare fraud.
Amazon, along with a host of other technology companies, is working on ways to use its smart speaker devices to bring a range of health care services into your home.
An array of products — from mattresses and sensors to sleep trackers and apps — are catching consumers’ attention. But privacy experts are concerned about what becomes of all the personal information these products collect.
For the seventh year in a row, Missouri will retain its lonely title as the only state without a statewide prescription drug monitoring program. Fears about privacy violations and gun control scuttled the bill yet again, leaving a pastiche of half-step measures in place to fill the void in the fight against prescription drug abuse.
Federal law bars insurers from using these test results for health coverage, but they can influence whether you get a plan covering long-term care.
Consumers, beware: Data brokers compile health and frailty profiles that have wide-ranging applications for drug companies, advertisers, insurers and other buyers.
Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Talking Points Memo discuss the latest on states’ efforts to reshape their Medicaid programs, the kerfuffle over President Donald Trump’s medical records and comments by former Health and Human Services Secretary Tom Price about Congress’ repeal of the Affordable Care Act’s “individual mandate” penalty. Rovner also interviews Harvard professor Robert Blendon about the complex politics of health in the coming midterm elections.
A lawsuit claims that a private company hired by the state public health department to manage enrollment in an AIDS drug assistance program for low-income patients inadvertently allowed unauthorized access to their medical status.
In a low-tech snafu, information about HIV treatment was visible through the cellophane window on envelopes sent to about 12,000 consumers.